Search

Search Results
Results 4391 - 4400 of 4688 for Movement Disorder
  • Prezista
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Prezista (darunavir) intended for persons living in Australia.
  • Prezcobix
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Prezcobix (Darunavir/cobicistat) intended for persons living in Australia.
  • Largactil
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Largactil intended for persons living in Australia.
  • Maxolon Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxolon Tablets intended for persons living in Australia.
  • Clozaril
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Opdualag
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Opdualag intended for persons living in Australia.
  • Levothox
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Levothox intended for persons living in Australia.
  • Ceftriaxone Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Ceftriaxone Viatris intended for persons living in Australia.
  • Sitting is the New Smoking
    Health - 30 Oct 2023
    Sedentary behavior or insufficient physical activity can negatively impact an individual's physical and mental health.
  • What are Recurrent Neural Networks?
    Health - 6 Sep 2023
    Recurrent neural networks are a classification of artificial neural networks used in artificial intelligence (AI), natural language processing (NLP), deep learning, and machine learning.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback